Patent · US Active

Antigen associated with the neovasculature of tumour metastases

US8263041B2 · kind B2 · utility

9Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2008
Grant dateSep 11, 2012
Priority date
Expiry dateMar 31, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of tumor metastases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.